Valuation Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. Other stock markets 05/08/2026			5-day change	1st Jan Change
992.30 ^PKR	+1.47%		-0.38%	-2.95%

05-19	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI
04-30	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	48,650	54,175	52,575	-	-
Change	-	11.36%	-2.95%	-	-
Enterprise Value (EV)	48,650	54,175	52,575	52,575	52,575
Change	-	11.36%	-2.95%	0%	0%
P/E	14.4x	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	1.96x	1.73x	1.54x	1.37x
EV / Revenue	-	0x	1.73x	1.54x	1.37x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	50	45	52	60
Rate of return	-	4.89%	4.53%	5.24%	6.05%
EPS ²	63.95	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	27,706	30,398	34,163	38,399
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income	3,389	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	918.22	1,022.49	992.30	992.30	992.30
Nbr of stocks (in thousands)	52,983	52,983	52,983	-	-
Announcement Date	26/3/25	7/4/26	-	-	-

¹PKR in Million²PKR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HIGHNOON LABORATORIES LIMITED	-	-	-	4.6%	187M
ELI LILLY AND COMPANY	34.02x	11.84x	24.88x	0.61%	995B
JOHNSON & JOHNSON	28.36x	6.26x	17.51x	2.11%	614B
ABBVIE INC.	31.72x	7.19x	14.9x	2.84%	431B
ROCHE HOLDING AG	19.93x	4.73x	11.72x	2.79%	353B
NOVARTIS AG	21.85x	5.66x	14.11x	2.84%	293B
ASTRAZENECA PLC	20.2x	4.19x	11.86x	2.11%	245B
AMGEN INC.	25.61x	6.68x	11.78x	2.59%	210B
NOVO NORDISK A/S	13.52x	5.15x	10.43x	3.7%	210B
GILEAD SCIENCES, INC.	-48.74x	5.83x	32.22x	2.44%	168B
Average	16.28x	6.39x	16.60x	2.66%	351.84B
Weighted average by Cap.	23.69x	7.54x	17.96x	2.04%